A Phase I and Pharmacokinetic Study of SR-45023A During a 14-Day Treatment Schedule

Trial Profile

A Phase I and Pharmacokinetic Study of SR-45023A During a 14-Day Treatment Schedule

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Sep 2018

At a glance

  • Drugs SR 45023A (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Sponsors Sanofi
  • Most Recent Events

    • 27 Aug 2018 Status changed from active, no longer recruiting to completed.
    • 27 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top